Patrick Parfrey

Title: Patrick Parfrey: Innovator in Cardiomyopathy Diagnostics

Introduction

Patrick Parfrey is a notable inventor based in St. John's, Canada. He has made significant contributions to the field of cardiomyopathy diagnostics, holding 2 patents that focus on innovative methods for diagnosing and treating this serious condition.

Latest Patents

His latest patents include a diagnostic test for cardiomyopathy. This invention describes methods and compositions related to diagnosing and treating cardiomyopathy, particularly focusing on arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C). The methods provided involve screening for, diagnosing, or detecting a risk of developing ARVD/C by identifying the presence of a transmembrane protein 43 (TMEM43) disease-associated variant in a subject's sample. The presence of this variant indicates that the subject has ARVD/C or an increased risk of developing it compared to individuals with wild type TMEM43.

Career Highlights

Throughout his career, Patrick has worked with several organizations, including Genesis Group Inc. and Memorial University of Newfoundland. His work has significantly impacted the understanding and treatment of cardiomyopathy.

Collaborations

Some of his notable coworkers include Terry-Lynn Young and Kathy Hodgkinson. Their collaborative efforts have contributed to advancements in the field of cardiomyopathy research.

Conclusion

Patrick Parfrey's innovative work in cardiomyopathy diagnostics showcases his dedication to improving patient outcomes through advanced medical technology. His contributions are vital in the ongoing fight against heart diseases.